Participants 129 187 5
advanced gastric or gastroesophageal cancer adenocarcinoma
Participants 221 290 4
For patients with advanced gastric or gastroesophageal cancer (AGGEC)
Participants 512 688 9
In a multinational trial (V325), 445 patients were randomly assigned and treated with either docetaxel plus cisplatin and fluorouracil (DCF) or cisplatin and fluorouracil (CF).
